703P Prognostic scores for immunotherapy-based phase one trials (P1T): To GRIm or not to GRIm?

Autor: Corbaux, P., Verlingue, L., Vanacker, H., Brahmi, M., Swalduz, A., Terret, C., Cassier, P., Vinceneux, A.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S488-S488
Databáze: ScienceDirect